SVP Clinical Development Jeffrey Wiezorek sold $1.4M of Kite Pharma, Inc.

Sold$1,350,144

$75.01Price

18,000Shares

−46%Stake

What KITE did after the filing

Prices for KITE after this filing aren't in yet.

Traded Wed, Mar 1. Filed Thu, Mar 2, 1:09 AM ET, before the open. Not investment advice.